OTCMKTS:PTEO Proteo (PTEO) Stock Price, News & Analysis $0.09 0.00 (0.00%) As of 09/27/2022 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Proteo Stock (OTCMKTS:PTEO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Proteo alerts:Sign Up Key Stats Today's Range$0.09▼$0.0950-Day Range$0.09▼$0.0952-Week Range$20.00▼$698.00VolumeN/AAverage Volume11 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewProteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company focuses on the development of pharmaceuticals based on Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands for use in the treatment of post-surgery damage to tissue; complications resulting from organ transplantation; pulmonary hypertension; and injuries caused by accidents, cardiac infarction, and other diseases. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded in 1992 and is based in Irvine, California.Read More… Receive PTEO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Proteo and its competitors with MarketBeat's FREE daily newsletter. Email Address PTEO Stock News HeadlinesHoy cumpliría 12 años Proteo, el perro rescatista que murió ayudando en el terremoto de TurquíaJune 17, 2025 | msn.comProteo: Ejército Mexicano recuerda con honor al perro rescatista que falleció en TurquíaFebruary 12, 2025 | msn.comA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking office, more than $12 trillion in private investments into America have been “practically committed” on his watch. "Nobody's ever seen numbers like we have," he said, crediting his agenda of tariffs, tax cuts, and deregulation with making the difference. If true, the figure would indeed be astonishing – potentially tripling the roughly $4 trillion in gross private investment the US reported all of last year.June 22, 2025 | Porter & Company (Ad)Proteo, el perro rescatista, sigue en el corazón de México a dos años de su última misión en TurquíaFebruary 12, 2025 | msn.comLTHO Legacy Technology Holdings, Inc.October 26, 2024 | seekingalpha.comITONF Ito En, Ltd. Class A Preferred SharesSeptember 28, 2024 | seekingalpha.comHomenaje a Proteo y el último desfile militar encabezado por AMLOSeptember 16, 2024 | msn.comKey Proteo seeks FDA approval for diagnostic newborn screening panelApril 1, 2024 | msn.comSee More Headlines PTEO Stock Analysis - Frequently Asked Questions How have PTEO shares performed this year? Proteo's stock was trading at $0.0899 on January 1st, 2025. Since then, PTEO stock has increased by 0.0% and is now trading at $0.0899. View the best growth stocks for 2025 here. How do I buy shares of Proteo? Shares of PTEO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Proteo own? Based on aggregate information from My MarketBeat watchlists, some other companies that Proteo investors own include ASAP (WTRH), Trigon Metals (TM), SoundThinking (SSTI), PagSeguro Digital (PAGS), Kaya (KAYS) and Energizer (ENR). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:PTEO CIK1063104 Webproteo.us Phone+1-949-2534616FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:PTEO) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Proteo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.